WASHINGTON, D.C.- The Association of Pharmaceutical Research and Development (APRaD), Kyiv,Ukraine, has joined the U.S.-Ukraine Business Council (USUBC).  Theannouncement was made today by the USUBC executive committee on behalf of theover 200 companies and organizations who are members of USUBC. 

The Association of Pharmaceutical Research and Development (APRaD) wasorganized by 18 world leading pharmaceutical companies active in the researchand development of new medicines that improve health and quality of life, witha presence in Ukraine.  APRaD brings together many of the world'spharmaceutical leaders: Abbott Laboratories, AstraZeneca, Bayer, BoehringerIngelheim, GlaxoSmithKline, Delta Medical, Eli Lilly, AbbVie BiopharmaceuticalsGmbH, Ipsen, Servier, Lundbeck, MSD Ukraine, Novartis Pharma, Novo Nordisk,Pfizer Ukraine, Roche Ukraine, Sanofi-Aventis Ukraine, and Janssen.  


Mission of APRaD is to provide a better access to innovativemedicines for Ukrainian citizens and innovative healthcare solutions aiming toimprove quality of life of  Ukrainians.The Association is the recognized voice of the research-basedpharmaceutical industry operating in Ukraine, to promote value of innovations,to conduct effective advocacy for public policies that improve access toquality medicines in Ukraine, and to be effective strategic partner to theGovernment of Ukraine.

The pharmaceutical industry, represented by APRaD, is committed to the researchand development, quality manufacturing and distribution of innovative medicinesthat save lives and reduce overall health carecosts. As a non-for-profit and non-governmental organization (NGO), APRaDworks in cooperation with Ukrainian authorities, and other internationalorganizations concerned with health and pharmaceutical industry-related issues.


The Association focuses on four major areas: Access to Medicines andReimbursement, Ethics, Partnership, and Intellectual Property Rights.

Specifically, APRaD:
         • Builds awareness about theR&D Pharmaceutical industry and original medicines;
          • Strives to resolveIntellectual Property Rights and Data Protection issues
          • Is the advocate for a betteraccess to quality medicines and establishment of reimbursement system;
          • Promotes and encourageethical business principles and practices among its members and thepharmaceutical industry in general;
          • Develops effectivepartnership with Government stakeholders as well as represent the interests ofthe pharmaceutical industry before all relevant authorities;
          • Establishesappropriate links with international pharmaceutical associations. 

The activities of the Association are not intended togenerate earnings. The Association has no intention whatsoever to create orpromote cartels or gentlemen's agreements and will put in place active measuresto ensure such arrangements do not arise. The Association does not engage in trade,commercial transactions or political activities.

APRaD cooperates with Ukrainian state institutions and agencies to provideanalysis and develop recommendations on new draft laws, amendments andsupplements to current legislation related to medicines circulation.This cooperation has been in place since the Association wascreated and is not limited only to state organizations. APRaD establishesand maintains professional relations with all target groups in this sphere.

APRaD has a very positive experience in cooperation with theCommittee on Public Health of the Verkhovna Rada of Ukraine, Ministry ofHealth, Ministry of Economy, State Committee of Ukraine for Regulatory Policyand Entrepreneurship, as well as with State Pharmacological Centre of the Ministryof Health of Ukraine, State inspectorate for quality control of medicines ofthe Ministry of Health of Ukraine, etc. 

APRaD is a member of the European Federation ofPharmaceutical Industries and Associations EFPIA, http://www.efpia.eu/and other international and nongovernmental organizations for the issuesrelated to legislation analysis in public healthcare.

To reach its objectives, APRaD functions through the followingStrategic Working Groups (SWGs): HC Reform, Pricing & Reimbursement SWG;Legislative & Regulatory + Registration Issues SWG, HR SWG, Ethics SWG.Strategic Working Groups are forums for discussing issues, developing commonopinions and positions, and acting respectively. 

USUBC is veryproud to welcome Association of Pharmaceutical Research and Development (APRaD)to its membership, said Morgan Williams, President and CEO, U.S.-Ukraine Business Council (USUBC). “We have already established very closebusiness relations with APRaD through  hosting and organizing mutualevents in Kyiv. 

Particularly,Pharmaceutical Industry Roundtable Discussions with Matthew Murray, DeputyAssistant Secretary, Office of Europe, Middle East, and Africa, U.S. Departmentof Commerce and Betsy Hafner, Deputy Assistant U.S. TradeRepresentative that took place in February and in April, 2015. We will continuemaintaining this dialog between U.S. and Ukraine in pharmaceutical industry issues,representing interests of both, Ukrainian citizens and business, Morgan William added.


Or contact Dr. Volodymyr Redko, Executive Director, Memberof Board, Kyiv, Ukraine
aprad.ukraine@gmail.com, t/f: +380(44) 493 91 30
NEWS: For the latest news about Ukraine go to the KYIV POST website: www.KyivPost.com.
The Kyiv Post of the ISTIL Group is a member of the U.S.-Ukraine BusinessCouncil (USUBC).  
NOTE:  If you do not wish to be on the U.S.-Ukraine Business Council(USUBC), distribution list please write to usubc@usubc.org.
U.S.-Ukraine Business Council(USUBC)
"A strong international voice for business in Ukraine for 20years"
1030 15th Street, N.W.,  Suite 555 W,Washington, D.C. 20005

E-mail: mwilliams@usubc.org.;Web: www.USUBC.org
Power Corrupts & AbsolutePower Corrupts Absolutely.